Previous 10 | Next 10 |
DaVita HealthCare Partners ( NYSE: DVA ) is scheduled to announce Q4 earnings results on Wednesday, February 22nd, after market close. The consensus EPS Estimate is $0.98 (-51.5% Y/Y) and the consensus Revenue Estimate is $2.93B (-0.3% Y/Y). Over the last 2 years, DVA has be...
Summary Berkshire Hathaway's 13F stock portfolio value increased from ~$296B to ~$299B. Their largest three holdings are at ~60% of the entire portfolio. Berkshire Hathaway increased Louisiana-Pacific while decreasing US Bancorp, Bank of New York Mellon, Taiwan Semi, and McKesson Co...
Summary Active investors can navigate the boom or bust biotech sector with the help of strategies like C-suite buying, cash to value and cash flow. Passive investors seeking a defensive position might just purchase the VanEck Pharmaceutical ETF and call it a year. Consider shorting ...
Summary During the fourth quarter, we purchased shares in DaVita. DaVita and Fresenius control a combined 80% of the $25 billion U.S. dialysis market. DaVita runs its business at relatively healthy low-teens operating margins. Assuming no revenue growth, we estimate DVA’s...
Summary Moon Capital Management, LLC is a SEC Registered Investment Adviser. Moon Capital helps individuals, families and institutions meet their financial goals by providing a full range of investment management and planning services. Our stock portfolio declined approximately 7% last ...
DaVita Inc. Schedules 4th Quarter 2022 Investor Conference Call PR Newswire DENVER , Feb. 1, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter and full year results on We...
DaVita Emphasized Holistic Care for Kidney Patients and Teammates in 2022 PR Newswire Company highlights major milestones achieved over the past year DENVER , Jan. 31, 2023 /PRNewswire/ -- Today, DaVita recognizes the impact its employees, known ...
Summary Pharmaceuticals and biotechnology have the best value and quality scores in the sector. Healthcare providers are close to their historical baseline in valuation and quality. Fast facts on GNOM. 10 stocks cheaper than their peers in January. This monthly article...
DaVita's Move It with Purpose Event Raises Funds for Bridge of Life PR Newswire The event has raised nearly $15 million for the nonprofit since 2007, enabling Bridge of Life to enhance kidney care globally through its medical missions. DENVER , Dec. 20, 2...
Summary Healthcare stocks have been strong recently and for the year amid heightened volatility. One healthcare provider has dealt with an unfavorable SCOTUS ruling and a big EPS miss in recent months. With impressive free cash flow expected offering upside potential, risks are seen...
News, Short Squeeze, Breakout and More Instantly...
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call PR Newswire DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, Aug...
2024-06-21 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...